Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple Negative Breast CancerClin. Cancer Res 2022 Jul 25;[EPub Ahead of Print], K Sun, Y Xu, L Zhang, P Niravath, J Darcourt, T Patel, BS Teh, AM Farach, C Guerrero, S Mathur, MA Sultenfuss, N Gupta, MR Schwartz, SL Haley, S Nair, X Li, TTA Nguyen, JD Butner, J Ensor, JA Mejia, Z Mei, EB Butler, SH Chen, EH Bernicker, JC Chang
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.